Stock Updates

How has Illumina Inc.:(NASDAQ:ILMN) performed recently?

Illumina Inc. (NASDAQ: ILMN) is a large market cap stock with a market cap of 24580.64. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 57.38, a forward P/E of 41.04 and EPS of 2.91. At a stock price of 165.82 (-0.66%) it has a dividend yield of *TBA.

EPS growth for the last five years have been 28.90%, more recently this last year it has grown by 30.50%. The next year growth is going to be about 15.87% and more long-term 15.97% after five years. EPS growth quarter over quarter is 18.60%. Sales growth for the past five years have been 19.70% and sales growth quarter over quarter is 11.30%.

For performance, Illumina Inc. the past week has seen a gain of 11.21%. For the last month performance for Illumina Inc. is 18.61%. While the last quarter is 24.89% and half year, 7.93%. Finally for the year, performance is -22.97%.

The 52-week high for Illumina Inc., is at -24.81%, and for the 52-week low it comes to a value of 30.46%. The 20-day simple moving average is 13.89% and 6.24% for the 200-day simple moving average.

Volatility for the week is at 5.10%, and for the month it is 3.09%. Illumina Inc., has a target price of 154.88.

In terms of debt, long term debt/equity is 0.48, and for total debt/equity Illumina Inc. has 0.48. The gross margin is 70.00%, while operating margin is 24.60%, the profit margin is 18.70%. The current ratio is 3.7 and the quick ratio is 3.1.

Insider ownership is at 1.20%, with instituitional ownership at 97.00%. Illumina Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 147.26. The shares float is 145.7, with the float short at 4.82%, with short ratio coming to 5.85.

In terms of returns, the return on assets see Illumina Inc., get 11.40%, with its returns on investment at 16.60%. Return on equity is 21.90%. So will the investors see the target price of 154.88, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment